Development and Implementation of Innovative Ultrasound Therapy Technologies (R01)

The summary for the Development and Implementation of Innovative Ultrasound Therapy Technologies (R01) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Development and Implementation of Innovative Ultrasound Therapy Technologies (R01): -Purpose. The primary goal of this initiative is to develop and accelerate the implementation of innovative, disruptive, non-invasive or minimally invasive ultrasound technologies that produce or enhance interventional therapies in humans. Research projects must focus on the solution of critical basic and/or technical problems that presently exist, and that have previously prevented these technologies from being implemented as safe and effective clinical therapies in humans. -This initiative is for a five-year award for applicant organizations that propose to develop disruptive ultrasound technologies that lead to implementation of safe and effective therapies. A disruptive technology is one that displaces existing dominant technology, due to its clear advantage(s) over previous technologies. This initiative encourages multidisciplinary collaborations and partnerships with industry.
Federal Grant Title: Development and Implementation of Innovative Ultrasound Therapy Technologies (R01)
Federal Agency Name: National Institutes of Health
Grant Categories: Health
Type of Opportunity: Discretionary
Funding Opportunity Number: RFA-EB-07-004
Type of Funding: Grant
CFDA Numbers: 93.849
CFDA Descriptions: Kidney Diseases, Urology and Hematology Research
Current Application Deadline: No deadline provided
Original Application Deadline: Jan 23, 2008
Posted Date: Nov 15, 2007
Creation Date: Nov 15, 2007
Archive Date: Feb 23, 2008
Total Program Funding: $5,000,000
Maximum Federal Grant Award:
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching: No
Applicants Eligible for this Grant
State governments Others (see text field entitled "Additional Information on Eligibility" for clarification) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Private institutions of higher education Native American tribal governments (Federally recognized) Independent school districts Public housing authorities/Indian housing authorities City or township governments Native American tribal organizations (other than Federally recognized tribal governments) Special district governments Small businesses County governments For profit organizations other than small businesses Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Public and State controlled institutions of higher education
Additional Information on Eligibility
Foreign institutions are eligible to apply.
Link to Full Grant Announcement
Information not provided
Grant Announcement Contact
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV
FBOWebmaster@OD.NIH.GOV If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
Similar Government Grants
Investigations on Primary Immunodeficiency Diseases (R01)
Grants for Basic Research in Glomerular Diseases (R01)
Advances in Polycystic Kidney Disease (R01)
Ancillary Studies of Kidney Disease Accessing Information from Clinical Trials, Epidemiolo...
Calcium Oxalate Stone Diseases (R01)
Research Grants for Clinical Studies of Kidney Diseases
Chronic Prostatitis Collaborative Research Network (Cpcrn)
Frequent Hemodialysis Clinical Trials
More Grants from the National Institutes of Health
Innovative Approaches to Studying Cancer Communication in the New Information Ecosystem (R...
Innovative Approaches to Studying Cancer Communication in the New Information Ecosystem (R...
Investigations on Primary Immunodeficiency Diseases/Inborn Errors of Immunity (R03 Clinica...
NIDA Program Project Grant Applications (P01 Clinical Trial Optional)
NCI Outstanding Investigator Award (R35 Clinical Trial Not Allowed)

FederalGrants.com is not endorsed by, or affiliated with, any government agency. Copyright ©2019 FederalGrants.com